mtrob

I set up an equal weighted AI mock portfolio a couple weeks ago just to watch, given the significant hype around them. Performance in a bit over 2 weeks is amusing to say the least

🇮🇩🚨 BREAKING!! Indonesia New Export Governance Scheme for Natural Resource Commodities The government is introducing a new export management system for natural resource commodities in two stages. Stage I: June 1–August 31, 2026 Companies will start shifting their export transactions to SOEs/BUMN. During this transition period, private companies still handle part of the process, but BUMN begins taking over transactions and contracts with overseas buyers. Stage II: Starting September 1, 2026 The system will be fully implemented. Export transactions with foreign buyers will be handled entirely by BUMN. This means BUMN will take full responsibility and authority over export management. The export process is divided into three main parts: 1. Pre-clearance Covers legal documents, permits, sales contracts, payment terms, packing, labeling, and cargo booking. 2. Clearance Covers export and customs documents, export duties, shipping documents, loading process, and customs clearance. 3. Post-clearance Covers export payment, document submission to banks, and confirmation after the goods are shipped. In short, the policy aims to move commodity export control from private companies to BUMN, with a transition period before full implementation.

I don’t agree. A PhD student should not prioritize work-life balance. Getting to do a PhD is a privilege. You are paid to think. There is no pressure for you to be economically useful. It is a unique opportunity to push the boundaries of human knowledge and produce something ground breaking. And nothing great ever happens without complete devotion. Look at everything that moved and shaped the world. Every single person who created anything meaningful, in science, in arts, in music, in movies, devoted their lives to their craft. Extraordinary outcomes require extraordinary inputs and some degree of sacrifice. Sure, have work-life balance during your PhD. But be content a mediocre outcome.

Like $IDYA at this stage, MC: $2.49b, Cash: $1.05b, EV: $1.49b. - Late-breaking abstract ASCO 2026 for complete data of Darovasertib + Crizo in 1L HLA-neg mUM - H2 2026 NDA submission for Daro + Crizo 1L HLA-neg mUM Still going for the whole UM space, primary (neo + adjuvant) and HLA-pos mUM trial ongoing

$AXSM (NP) From today's trades